BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10646889)

  • 1. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
    Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
    Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human glandular kallikrein hK2 from LNCaP cells.
    Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
    J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
    Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
    Bodey B; Bodey B; Kaiser HE
    Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
    Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
    Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
    J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
    Bridon DP; Dowell BL
    Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
    Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
    Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen may serve as a pathological predictor in breast cancer.
    Nariţa D; Anghel A; Motoc M
    Rom J Morphol Embryol; 2008; 49(2):173-80. PubMed ID: 18516323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches].
    Seliger E; Kaltwasser P; Röpke F
    Zentralbl Gynakol; 1998; 120(4):172-5. PubMed ID: 9610520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.
    Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS
    Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen (PSA) in women.
    Yu H; Berkel H
    J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.